Life sciences professionals engaged in transparency reporting understand the myriad of challenges in compiling necessary data for reporting. Navigating challenges such as incomplete records, [...]
MediSpend’s legal experts recently presented a webinar shedding light on the recent transparency updates within the life science industry. The presentation covered key topics, such [...]
On November 6, 2023, the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG), in connection with the November 2023 [...]
MediSpend’s Advisory Services team recently presented a webinar on emerging transparency updates and requirements for pharmaceutical and medical device manufacturers. Notable updates included changes [...]
The Centers for Medicare and Medicaid Services (CMS) recently published their 2022 Open Payments data as well as newly submitted and updated payment records [...]
Life sciences organizations are subject to numerous legal and regulatory requirements, including an obligation to screen the healthcare professionals and organizations (HCP/Os) that they [...]
Recently, MediSpend’s Advisory Services team presented a webinar on emerging transparency updates and requirements for pharmaceutical and medical device manufacturers. Notable updates included changes [...]
For life sciences companies, launching your first product is a busy and critical time. In addition to sorting out launch plans, supply chain, field [...]
For life science companies, paid engagements with healthcare professionals and organizations (HCP/O) are crucial to growing your business. However, with enforcers turning a closer [...]
Many life sciences companies could be missing a key opportunity by not proactively leveraging their aggregated spend data and the publicly available CMS Open [...]
As one of the most regulated industries in the world, life science organizations need a well-developed compliance plan to stay ahead of the game. [...]
In July 2021, Oregon’s governor signed into law Senate Bill 763 requiring pharmaceutical representatives to obtain a license prior to marketing or promoting products [...]
Many life sciences companies are using manual processes or inefficient software to manage their end-to-end workflow process associated with educational, sponsorship, charitable and/or research [...]
On July 23, 2021, the Centers for Medicare and Medicaid Services (CMS) published a draft of the calendar year 2022 payment policies under the [...]
The Centers for Medicare and Medicaid Services (CMS) recently published their 2020 Open Payments data as well as newly submitted and updated payment records [...]
On May 19, 2021, the Department of Justice (DOJ) announced a civil settlement in the Eastern District of Pennsylvania with Medicrea International, a French [...]
Intuitive grants processes benefit both external applicants and the life sciences companies who support them. For life sciences companies, one of the most critical [...]
The Centers for Medicare & Medicaid Services (CMS) recently held two webinars regarding the 2021 Open Payments program expansion as well as the review [...]
The Centers for Medicare and Medicaid Services (CMS) recently published their 2021 Open Payments data as well as newly submitted and updated payment records [...]
Since January 1, 2021, MedTech Europe and the European Federation of Pharmaceutical Industries and Associations (EFPIA) have a common platform assessing medical conferences. The [...]
On January 1, 2021, the Medicines New Zealand and New Zealand Medical Association (NZMA) Joint Transparency Initiative went into effect. “This initiative aims to [...]
In Lithuania, the Pharmacy Law was amended to add a disclosure obligation for marketing authorization holders (MAHs) regarding transfers of value (ToVs) to healthcare [...]
A special fraud alert was issued by the Office of the Inspector General (OIG) on November 16, 2020 highlighting the potential fraud and abuse [...]
Earlier this year, we published a blog highlighting the French Decree on ‘anti-gifts’ that was published on June 17, 2020.[1] Additional ‘orders’ related to [...]
The landscape of meeting compliance needs within life sciences is changing. Today, life sciences organizations are rapidly shifting to a digital centric world. This [...]
If your organization is like most these days, resources are tight and teams are lean. Efficiency becomes a key ingredient to an effective compliance [...]
Introduction One of the key areas of focus for compliance teams is pre-empting and managing risk across the organization before it becomes a compliance [...]
As engagements between life sciences companies and healthcare professionals (HCPs) become more frequent and complex, the financial ties associated with those engagements continue to [...]
Building a transparency reporting program is easy. Building an effective transparency reporting program, however, is much more challenging. Partnering with over a hundred medical [...]
The Centers for Medicare & Medicaid Services recently published their 2019 Open Payments data. In the 2019 report, which includes transactions that took place [...]
-
On June 17, 2020, an important decree related to “anti-benefits” was published in France, including the ministerial orders implementing this decree. The new rules [...]
The Maine Board of Pharmacy finalized its gift ban rule last month, providing guidance for manufacturers and wholesalers over a year after initial regulations [...]
As mentioned in a blog published last year, EPFIA consolidated their three EFPIA Codes (PO – HCP – Disclosure) into one simplified Code. EFPIA stated their [...]
1. Implementation Time Investment A migration to a SaaS solution may seem intimidating and you might have concerns about the bandwidth of your IT [...]
On June 1, 2020, the Department of Justice (DOJ) updated its guidance document on the “Evaluation of Corporate Compliance Programs.” As outlined below, the [...]
While the healthcare industry has always been highly regulated, recent developments mandate that transparency and compliance monitoring are not afterthoughts for manufacturers, healthcare organizations [...]
The Massachusetts Department of Public Health requires pharmaceutical and medical device manufacturers to disclose certain transactions with anyone who prescribes, dispenses, or purchases prescription [...]
The fundamentals of good compliance require the ability for compliance professionals to intercede, either prospectively or retrospectively, at key control points. Whether these are [...]
Whether you’ve just completed your first submission to Centers for Medicare & Medicaid Services (CMS), or you’ve had a transparency reporting program in place [...]
Meeting US federal, US state and international transparency reporting requirements requires a substantial amount of time and resources from you and your team. Regulations [...]
In-House Costs for Existing Systems For an existing in-house system, calculate the total cost of ownership for: Researching current regulations and making system updates [...]
On April 7th, MediSpend hosted the webinar What Does the CCPA Mean for Life Sciences Companies, where we provided an overview of the California [...]
You know you need to modernize and improve your transparency reporting program. But how? In a recent assessment of aggregate-spend tracking and transparency reporting [...]
Are you a small pharmaceutical or medical device company with limited resources worried about implementing a software solution like MediSpend? Are you a larger [...]
-
If you have not considered an integrated HCP engagement and transparency reporting solution, you should. Here’s why: Hand in hand with developing new treatments [...]
On March 11, days before most U.S. businesses across the country had to close their doors to fight the spread of COVID-19, the California [...]
Transparency reporting requirements for life sciences companies are increasing all over the world. The United States was the first country to enact comprehensive transparency [...]
An effective technology solution should follow the seven steps outlined below to ensure a systematic methodology is in place to apply controls throughout the [...]
For years, industry payments to physicians have been scrutinized by enforcement agencies, politicians and watchdog groups. In fact, the government has been playing an [...]
On November 15, 2019, the Centers for Medicare & Medicaid Services (CMS) published the final 2020 Physician Fee Schedule which, along with the October [...]
The industry has effectively used technology for decades in every facet of the business. From enterprise resource management to CRM platforms, technology has been [...]
The Accreditation Council for Continuing Medical Education (ACCME) invited comments about the proposed revisions to the rules that protect the independence and integrity of [...]
Chief compliance officers have struggled at the bottom of the food chain for both budget and technology for years. While revenue generating departments have [...]
-
March 31, 2020 is quickly approaching which means many pharmaceutical and medical device companies are feeling the pressure of the looming CMS Open Payments [...]
It’s time to make global compliance a breeze
Give us 15 minutes and we’ll show you why MediSpend is a market-leading, cost-effective and proven solution for global compliance in the life science industry. Contact us and we’ll help you make global compliance a breeze!
